| Name | Title | Contact Details |
|---|
Pyramid HealthCare provides on-site Rehabilitation to individuals whose level of independence is threatened by physical injury or illness. Assessment and training in functional skills by licensed Physical, Occupational and Speech Therapists helps the
OncoGenex is a biopharmaceutical company committed to the development and commercialization of new therapies that address treatment resistance in cancer patients. OncoGenex has a diverse oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. OncoGenex and Teva Pharmaceutical Industries Ltd. have entered a global collaboration and licensing agreement to develop and commercialize OncoGenex' lead drug candidate, custirsen. Custirsen is currently in Phase 3 clinical development as a treatment in men with metastatic castrate-resistant prostate cancer and in patients with advanced, unresectable non-small cell lung cancer. Apatorsen is in Phase 2 clinical development and OGX-225 is currently in pre-clinical development.
MedVentive provides leading-edge technology solutions that enable physician groups, integrated delivery systems, health plans and self-insured employers to effect meaningful and measurable change in the quality and cost of care they deliver to patients.
IN Compass Health is a Alpharetta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Hycor Biomedical Inc. is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.